Vaxxass is a developer of novel vaccine delivery medical devices focused on improving the performance of existing vaccines and vaccines through its patented High Density Microarray Patch (HD-MAP), the company is targeting initial application. Recently, Vaxxas received USD 23 million in Series C financing, invested by Uniquest and One Ventures.
This article is transferred from: https://www.itjuzi.com/investevent/13702724
This site is only for collection, and the copyright belongs to the original author.